Napp Logo - A member of the Mundipharma network of associated companies
Report adverse event Login Register

Your browser is not supported.

To view this content, please use one of the following browsers:

  • Microsoft Edge
  • Chrome
  • Safari

Articles

frame 6

How can primary care professionals reduce the burden of asthma exacerbations and improve asthma control in the real world?

Respiratory

Job Code : 

JOB CODE: UK-INV-2200045 | DOP: November 2022
Read More

Prescribing information for Flutiform (fluticasone propionate/formoterol)

Prescribing information for Flutiform
Header image breathing difficulties

The ongoing dilemma of phenotyping vs stepping up or down in asthma therapy

Respiratory

Job Code : 

JOB CODE: UK-INV-2200045 | DOP: November 2022
Read More

Prescribing information for Flutiform (fluticasone propionate/formoterol)

Prescribing information for Flutiform
banner-image

Optimising referral criteria to specialty care in severe asthma

Respiratory

Job Code : 

JOB CODE: UK-INV-2200045 | DOP: November 2022
Read More

Prescribing information for Flutiform (fluticasone propionate/formoterol)

Prescribing information for Flutiform

Reporting adverse events

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard.

Adverse events should also be reported to Napp Pharmaceuticals Limited on 01223 424444 or drugsafetyUKandROI@mundipharma.com.